Connect Biopharma Holdings (CNTB) Net Cash Flow (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Net Cash Flow of $7.6 million for Q1 2026, up 1596.44% sequentially from $449000.0 in Q4 2025, and up 124.89% YoY from $3.4 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Net Cash Flow (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Net Cash Flow for 3 years, with the latest figure at $7.6 million in Q1 2026.
- Quarterly Net Cash Flow rose 124.89% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (up 96.85% YoY) and the FY2025 annual result came in at -$40.3 million, down 50.15% from the prior year.
- Net Cash Flow advanced to $7.6 million in Q1 2026 per CNTB's latest filing, from $449000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $8.7 million in Q1 2024 and troughed at -$30.6 million in Q1 2025.
- A 3-year average of -$6.6 million and a median of -$4.4 million in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2025 and 2026: Net Cash Flow tumbled 453.37% in 2025, then jumped 124.89% in 2026.
- Over 3 years, Net Cash Flow stood at -$18.0 million in 2024, then jumped by 102.5% to $449000.0 in 2025, then jumped by 1596.44% to $7.6 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $7.6 million, $449000.0, and -$2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | -19.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.06 Mn |
| Jun 30, 2026 | -19.06 Mn |
| Mar 31, 2026 | 7.62 Mn |
| Mar 31, 2026 | 7.62 Mn |
| Dec 31, 2025 | 449,000.00 |
| Dec 31, 2025 | 449,000.00 |
| Sep 30, 2025 | -2.85 Mn |
| Sep 30, 2025 | -2.85 Mn |
| Jun 30, 2025 | -7.30 Mn |
| Jun 30, 2025 | -7.30 Mn |
| Mar 31, 2025 | -30.60 Mn |
| Mar 31, 2025 | -30.60 Mn |
| Dec 31, 2024 | -17.98 Mn |
| Dec 31, 2024 | -17.98 Mn |
| Sep 30, 2024 | -13.15 Mn |
| Sep 30, 2024 | -13.15 Mn |
| Jun 30, 2024 | -4.36 Mn |
| Jun 30, 2024 | -4.36 Mn |
| Mar 31, 2024 | 8.66 Mn |
| Mar 31, 2024 | 8.66 Mn |